Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05326373 · ClinicalTrials.gov registry record · NA
Stannous Fluoride and Gingivitis
A NA study, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT05326373 is a NA study that has completed, run by Procter and Gamble. The registered enrollment target is 40 participants.
The verdict
NCT05326373, a NA study, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
8-week study using stannous fluoride toothpaste on subjects with gingivitis ("unhealthy") and without gingivitis ("healthy"). Gingivitis index will be performed at BL, Week 4 and Week 8. A number of biological samples will be collected at each timepoint.
Interventions
- DRUG Stannous fluoride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-04-11 |
| Est. Completion | 2022-06-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05326373
The ClinicalTrials.gov registry entry for NCT05326373 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stannous fluoride is the first listed.
NCT05326373 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05326373 about?
NCT05326373 is a clinical study titled "Stannous Fluoride and Gingivitis". 8-week study using stannous fluoride toothpaste on subjects with gingivitis ("unhealthy") and without gingivitis ("healthy"). Gingivitis index will be performed at BL, Week 4 and Week 8. A number of biological samples will be collected at each timepoint.
What is the current status of trial NCT05326373?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-04-11. Estimated completion is 2022-06-13.
What interventions are being tested in trial NCT05326373?
The interventions under investigation include: Stannous fluoride (DRUG).
Who is sponsoring clinical trial NCT05326373?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.